Found: 9
Select item for more details and to access through your institution.
Image segmentation of liver fibrosis.
- Published in:
- Journal of Microscopy, 2008, v. 231, n. 1, p. 70, doi. 10.1111/j.1365-2818.2008.02018.x
- By:
- Publication type:
- Article
Review article: drug hepatotoxicity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 25, n. 10, p. 1135, doi. 10.1111/j.1365-2036.2007.03307.x
- By:
- Publication type:
- Article
Pneumatosis intestinalis and mesenteric venous gas - A manifestation of bacterascites in a patient with cirrhosis.
- Published in:
- Journal of Postgraduate Medicine, 2011, v. 57, n. 1, p. 42, doi. 10.4103/0022-3859.74287
- By:
- Publication type:
- Article
Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.
- Published in:
- Transplant Infectious Disease, 2008, v. 10, n. 3, p. 184, doi. 10.1111/j.1399-3062.2007.00258.x
- By:
- Publication type:
- Article
Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL- HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study.
- Published in:
- Journal of Viral Hepatitis, 2017, v. 24, n. 3, p. 197, doi. 10.1111/jvh.12632
- By:
- Publication type:
- Article
High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens.
- Published in:
- Journal of Viral Hepatitis, 2016, v. 23, n. 9, p. 667, doi. 10.1111/jvh.12530
- By:
- Publication type:
- Article
Randomised clinical study: GR- MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 11/12, p. 1183, doi. 10.1111/apt.13816
- By:
- Publication type:
- Article
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 5, p. 543, doi. 10.1111/apt.12641
- By:
- Publication type:
- Article
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 2, p. 209, doi. 10.1111/apt.12560
- By:
- Publication type:
- Article